186 related articles for article (PubMed ID: 16330982)
1. The Otto Aufranc Award: bone augmentation around and within porous implants by local bisphosphonate elution.
Tanzer M; Karabasz D; Krygier JJ; Cohen R; Bobyn JD
Clin Orthop Relat Res; 2005 Dec; 441():30-9. PubMed ID: 16330982
[TBL] [Abstract][Full Text] [Related]
2. Zoledronic acid causes enhancement of bone growth into porous implants.
Bobyn JD; Hacking SA; Krygier JJ; Harvey EJ; Little DG; Tanzer M
J Bone Joint Surg Br; 2005 Mar; 87(3):416-20. PubMed ID: 15773657
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate remains highly localized after elution from porous implants.
McKenzie K; Dennis Bobyn J; Roberts J; Karabasz D; Tanzer M
Clin Orthop Relat Res; 2011 Feb; 469(2):514-22. PubMed ID: 20809167
[TBL] [Abstract][Full Text] [Related]
4. Implant-delivered Alendronate Causes a Dose-dependent Response on Net Bone Formation Around Porous Titanium Implants in Canines.
Pura JA; Bobyn JD; Tanzer M
Clin Orthop Relat Res; 2016 May; 474(5):1224-33. PubMed ID: 26831478
[TBL] [Abstract][Full Text] [Related]
5. Effects of systemic zoledronic Acid administration on osseointegration of hydroxyapatite-coated and resorbable blast material surface implants in rabbit models.
Yaman F; Ağaçayak S; Atilgan S; Benlidayi E; Ucan MC; Erol B; Kaya B; Gunay A; Guven S
Int J Oral Maxillofac Implants; 2012; 27(6):1443-7. PubMed ID: 23189295
[TBL] [Abstract][Full Text] [Related]
6. Local delivery of a zoledronate solution improves osseointegration of titanium implants in a rat distal femur model.
AbuMoussa S; Ruppert DS; Lindsay C; Dahners L; Weinhold P
J Orthop Res; 2018 Dec; 36(12):3294-3298. PubMed ID: 30117189
[TBL] [Abstract][Full Text] [Related]
7. Local bisphosphonate treatment increases fixation of hydroxyapatite-coated implants inserted with bone compaction.
Jakobsen T; Baas J; Kold S; Bechtold JE; Elmengaard B; Søballe K
J Orthop Res; 2009 Feb; 27(2):189-94. PubMed ID: 18752278
[TBL] [Abstract][Full Text] [Related]
8. Enhanced gap filling and osteoconduction associated with alendronate-calcium phosphate-coated porous tantalum.
Garbuz DS; Hu Y; Kim WY; Duan K; Masri BA; Oxland TR; Burt H; Wang R; Duncan CP
J Bone Joint Surg Am; 2008 May; 90(5):1090-100. PubMed ID: 18451402
[TBL] [Abstract][Full Text] [Related]
9. Local alendronic acid elution increases net periimplant bone formation: a micro-CT analysis.
Bobyn JD; Thompson R; Lim L; Pura JA; Bobyn K; Tanzer M
Clin Orthop Relat Res; 2014 Feb; 472(2):687-94. PubMed ID: 23813239
[TBL] [Abstract][Full Text] [Related]
10. The effects of zoledronic acid and dexamethasone on osseointegration of endosseous implants: histological and histomorphometrical evaluation in rats.
de Oliveira MA; Asahi DA; Silveira CAE; Lima LAPA; Glick M; Gallottini M
Clin Oral Implants Res; 2015 Apr; 26(4):e17-e21. PubMed ID: 24438459
[TBL] [Abstract][Full Text] [Related]
11. Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface.
Li YF; Li XD; Bao CY; Chen QM; Zhang H; Hu J
Osteoporos Int; 2013 Mar; 24(3):1063-71. PubMed ID: 23296744
[TBL] [Abstract][Full Text] [Related]
12. A single dose of zoledronic acid reverses the deleterious effects of glucocorticoids on titanium implant osseointegration.
Carvas JS; Pereira RM; Caparbo VF; Fuller P; Silveira CA; Lima LA; Bonfa E; Mello SB
Osteoporos Int; 2010 Oct; 21(10):1723-9. PubMed ID: 19997905
[TBL] [Abstract][Full Text] [Related]
13. Systemic sclerostin antibody treatment increases osseointegration and biomechanical competence of zoledronic-acid-coated dental implants in a rat osteoporosis model.
Korn P; Kramer I; Schlottig F; Tödtman N; Eckelt U; Bürki A; Ferguson SJ; Kautz A; Schnabelrauch M; Range U; Kneissel M; Stadlinger B
Eur Cell Mater; 2019 May; 37():333-346. PubMed ID: 31112281
[TBL] [Abstract][Full Text] [Related]
14. The bisphosphonate ibandronate accelerates osseointegration of hydroxyapatite-coated cementless implants in an animal model.
Eberhardt C; Habermann B; Müller S; Schwarz M; Bauss F; Kurth AH
J Orthop Sci; 2007 Jan; 12(1):61-6. PubMed ID: 17260119
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of periprosthetic bone quality with topical hydroxyapatite-bisphosphonate composite.
Suratwala SJ; Cho SK; van Raalte JJ; Park SH; Seo SW; Chang SS; Gardner TR; Lee FY
J Bone Joint Surg Am; 2008 Oct; 90(10):2189-96. PubMed ID: 18829917
[TBL] [Abstract][Full Text] [Related]
16. Early healing of hydroxyapatite-coated implants in grafted bone of zoledronic acid-treated osteoporotic rabbits.
Li JP; Li P; Hu J; Dong W; Liao NN; Qi MC; Li JY
J Periodontol; 2014 Feb; 85(2):308-16. PubMed ID: 23688100
[TBL] [Abstract][Full Text] [Related]
17. Local delivery of zoledronate from a poly (D,L-lactide)-Coating increases fixation of press-fit implants.
Jakobsen T; Bechtold JE; Søballe K; Jensen T; Greiner S; Vestermark MT; Baas J
J Orthop Res; 2016 Jan; 34(1):65-71. PubMed ID: 26177742
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of bone growth into porous intramedullary implants using non-invasive low intensity ultrasound.
Tanzer M; Kantor S; Bobyn JD
J Orthop Res; 2001 Mar; 19(2):195-9. PubMed ID: 11347690
[TBL] [Abstract][Full Text] [Related]
19. Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study.
Stadelmann VA; Gauthier O; Terrier A; Bouler JM; Pioletti DP
Eur Cell Mater; 2008 Jul; 16():10-6. PubMed ID: 18671203
[TBL] [Abstract][Full Text] [Related]
20. Systemically administered zoledronic acid activates locally implanted synthetic hydroxyapatite particles enhancing peri-implant bone formation: A regenerative medicine approach to improve fracture fixation.
Markeviciute V; Puthia M; Arvidsson L; Liu Y; Törnquist E; Tengattini A; Huang J; Bai Y; Vater C; Petrolis R; Zwingenberger S; Krisciukaitis A; Smailys A; Lukosevicius S; Stravinskas M; Isaksson H; Tarasevicius S; Lidgren L; Tägil M; Raina DB
Acta Biomater; 2024 Apr; 179():354-370. PubMed ID: 38490481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
